Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective [PMID: 36077374] Laboratory literature summary: NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective investigational Targets
When two compounds have similar half-lives, their plasma concentrations rise and fall together with each weekly research administration
Your provider will determine the most appropriate treatment options based on current medical guidelines, clinical evidence, and your individual health profile
While we believe they should be required to fund or run research for these types of indications, we must act now, with or without them
US$ 26.87
US$ 20.09
US$ 24.43
US$ 27.96
US$ 27.61
US$ 29.28
US$ 25.51
